# Phenotype and Prognosis of Patients With Breast Cancer and Pathogenic Variants of TP53

> **NCT04966923** · — · COMPLETED · sponsor: **Instituto do Cancer do Estado de São Paulo** · enrollment: 135 (actual)

## Conditions studied

- Breast Cancer
- TP53 R337H
- Li-Fraumeni Syndrome
- Prognosis Breast Cancer

## Interventions

- **OTHER:** No intervention in this study

## Key facts

- **NCT ID:** NCT04966923
- **Lead sponsor:** Instituto do Cancer do Estado de São Paulo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-02
- **Primary completion:** 2021-08-07
- **Final completion:** 2022-02-22
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2022-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04966923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04966923, "Phenotype and Prognosis of Patients With Breast Cancer and Pathogenic Variants of TP53". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04966923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*